The effect of combination therapy with rituximab and intravenous immunoglobulin on the progression of chronic antibody mediated rejection in renal transplant recipients

Journal of immunology research

Volumn 2014, Issue , 2014, Pages 828732-

  An, Gun H ee ^a   Yun, Jintak ^a   Hong, Yu A h ^a   Khvan, Marina ^a   Chung, Byung H a ^a   Choi, Bum S oon ^a   Park, Cheol W hee ^a   Choi, Yeong J in ^a   Kim, Yong Soo ^a   Yang, Chul W oo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY; RITUXIMAB;

ADULT; BLOOD; CHRONIC DISEASE; DISEASE COURSE; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PATHOLOGY; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME;

ADULT; ANTIBODIES; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CHRONIC DISEASE; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME;

EID: 84921925220     PISSN: None     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/828732     Document Type: Article

References (0)